CELLCEUTIX INC News Headlines

CTIX 
$3.68
*  
0.02
0.55 %
Get CTIX Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading CTIX now


Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
2/13/2015 4:00:00 PM - Seeking Alpha


IHUB Most Posted And Most Read Stocks Do Not Perform Well
2/11/2015 9:43:00 AM - Seeking Alpha


An Interview With Cellceutix CEO Leo Ehrlich
2/9/2015 10:31:00 AM - Seeking Alpha


Cellceutix: Why An Uplisting Is Not Possible Right Now
2/6/2015 2:26:00 PM - Seeking Alpha


$CTIX - Cellceutix Undervalued By 90+%; Expect A Short Squeeze Soon
1/29/2015 4:13:00 PM - Seeking Alpha


Cellceutix: A December To Remember May Turn Into A 2015 To Forget For CTIX
1/23/2015 10:30:00 AM - Seeking Alpha


Cellceutix Overvalued By 90-99%
1/2/2015 5:21:00 PM - Seeking Alpha


CorMedix Update: Setting A New Standard For Catheter Care
12/28/2014 7:07:00 AM - Seeking Alpha


New Use For AMGN's Old Drug, BLUE In The Pink, Cellceutix Gets A Boost
12/9/2014 12:49:00 AM - RTT News


Cellceutix Antibiotic Brilacidin Receives QIDP Designation From FDA
12/8/2014 7:29:00 AM - RTT News


Regulatory Support Creates Opportunity For Antibiotic Makers Otonomy And Cellceutix
9/25/2014 10:02:00 AM - Seeking Alpha


Update: Cellceutix Calls Out To President Obama About Brilacidin
9/21/2014 3:38:00 PM - Seeking Alpha


Update: Cellceutix's Antibiotic Brilacidin Should Move Share Price Before Kevetrin Or Prurisol
9/14/2014 3:06:00 AM - Seeking Alpha


The Antibiotic Resistance Triple Threat
9/4/2014 2:05:00 PM - Seeking Alpha


Did The Medicines Company Trump Cellceutix And Others In A $1B-Plus Skin Infection Market?
8/14/2014 11:38:00 AM - Seeking Alpha


Huge Opportunities Are Now Possible Due To Market Inefficiencies In Valuing Antibiotic Companies Such As Cubist, Durata, And Cellceutix
4/25/2014 10:34:00 AM - Seeking Alpha


Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin
1/28/2014 9:31:00 AM - Seeking Alpha


Cellceutix: An Undiscovered Company Set To Rise In 2014
12/16/2013 9:06:00 AM - Seeking Alpha